Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Ligand Binding Sites02:40

Ligand Binding Sites

Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
The Equilibrium Binding Constant and Binding Strength02:18

The Equilibrium Binding Constant and Binding Strength

The equilibrium binding constant (Kb) quantifies the strength of a protein-ligand interaction. Kb can be calculated as follows when the reaction is at equilibrium:
Conserved Binding Sites01:49

Conserved Binding Sites

Many proteins’ biological role depends on their interactions with their ligands, small molecules that bind to specific locations on the protein known as ligand-binding sites. Ligand-binding sites are often conserved among homologous proteins as these sites are critical for protein function.
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally analyses the...
Protein-protein Interfaces02:04

Protein-protein Interfaces

Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a polypeptide...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

CSCAN: Conformational Analysis of Macrocyclic Peptides through NMR Chemical Shifts.

Journal of chemical information and modeling·2026
Same author

Structure-based pose prediction: Non-cognate docking extended to macrocyclic ligands.

Journal of computer-aided molecular design·2024
Same author

From UK-2A to florylpicoxamid: Active learning to identify a mimic of a macrocyclic natural product.

Journal of computer-aided molecular design·2024
Same author

Correction: Complex peptide macrocycle optimization: combining NMR restraints with conformational analysis to guide structure-based and ligand-based design.

Journal of computer-aided molecular design·2024
Same author

Complex peptide macrocycle optimization: combining NMR restraints with conformational analysis to guide structure-based and ligand-based design.

Journal of computer-aided molecular design·2023
Same author

Unmasking the True Identity of Rapamycin's Minor Conformer.

Journal of natural products·2023

Related Experiment Video

Updated: Jul 9, 2026

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis
08:49

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis

Published on: June 20, 2025

Bias, reporting, and sharing: computational evaluations of docking methods.

Ajay N Jain1

  • 1University of California San Francisco, Box 0128, San Francisco, CA 94143-0128, USA. ajain@jainlab.org

Journal of Computer-Aided Molecular Design
|December 14, 2007
PubMed
Summary
This summary is machine-generated.

This study highlights the lack of standards in computational docking for drug discovery, identifying critical issues in data sharing, dataset design, and reporting that hinder real-world performance and transparency. Recommendations for best practices are provided to improve methodological evaluation and reproducibility.

More Related Videos

A Bilingual Computational Workflow for Identifying Potential PLK1 Inhibitors in American Sign Language and English
14:34

A Bilingual Computational Workflow for Identifying Potential PLK1 Inhibitors in American Sign Language and English

Published on: April 3, 2026

Related Experiment Videos

Last Updated: Jul 9, 2026

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis
08:49

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis

Published on: June 20, 2025

A Bilingual Computational Workflow for Identifying Potential PLK1 Inhibitors in American Sign Language and English
14:34

A Bilingual Computational Workflow for Identifying Potential PLK1 Inhibitors in American Sign Language and English

Published on: April 3, 2026

Area of Science:

  • Computational chemistry
  • Drug discovery
  • Bioinformatics

Background:

  • Computational docking is widely used in drug discovery to predict ligand-protein interactions.
  • The field lacks established standards for evaluating docking accuracy, virtual screening utility, and scoring performance.
  • Existing methodologies face challenges in data sharing, dataset preparation, and statistical reporting, impacting translation to real-world applications.

Purpose of the Study:

  • To identify and illustrate critical pitfalls in the methodological evaluation of computational docking.
  • To propose best practices for data sharing, dataset design, and statistical reporting in docking studies.
  • To enhance the transparency and reproducibility of docking method development and performance assessment.

Main Methods:

  • Analysis of common practices and challenges in computational docking studies.
  • Detailed examples of pitfalls in data sharing, dataset design, and statistical reporting.
  • Formulation of recommendations for standardized evaluation and best practices.

Main Results:

  • Significant issues identified in data sharing, leading to limited reproducibility.
  • Inconsistencies in dataset design and preparation affect the reliability of docking results.
  • Lack of standardized statistical reporting obscures the true performance of docking methods.
  • The relationship between methodological changes and reported performance improvements is often unclear.

Conclusions:

  • Establishing clear standards for docking evaluation is crucial for advancing drug discovery.
  • Improved data sharing, rigorous dataset design, and transparent statistical reporting are essential.
  • Adopting best practices will enhance the reliability and real-world applicability of computational docking methods.